Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration.

@article{Baragetti2007ImprovementOE,
  title={Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration.},
  author={I. Baragetti and S. Raselli and A. Stucchi and V. Terraneo and S. Furiani and L. Buzzi and K. Garlaschelli and E. Alberghini and A. Catapano and G. Buccianti},
  journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association},
  year={2007},
  volume={22 11},
  pages={
          3292-7
        }
}
  • I. Baragetti, S. Raselli, +7 authors G. Buccianti
  • Published 2007
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
BACKGROUND Hyperhomocysteinaemia is an independent risk factor for the development of atherosclerosis. Furthermore, homocysteine induces endothelial dysfunction by an increased inactivation of nitric oxide. In patients with chronic renal failure, the administration of folic acid or its metabolites reduces but does not normalize plasma homocysteine concentrations. METHODS We examined the effect of oral treatment with 15 mg/daily of 5-methyltetrahydrofolate (5-MTHF) for 12 weeks, on… Expand
5-Methyltetrahydrofolate Administration Is Associated with Prolonged Survival and Reduced Inflammation in ESRD Patients
Influence of diabetes on homocysteine-lowering therapy in chronic hemodialysis patients.
Hyperhomocysteinaemia and endothelial dysfunction in dialysis patients: what should be treated first?
  • M. Righetti
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2008
Cardiovascular disease on hemodialysis: Predictors of atherosclerosis and survival
Micronutrient Metabolism in Hemodialysis Patients
Cardiovascular risk in the peritoneal dialysis patient
...
1
2
...

References

SHOWING 1-10 OF 33 REFERENCES
5-methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis.
  • G. Buccianti, S. Raselli, +6 authors A. Catapano
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2002
Folic Acid Treatment of Hyperhomocysteinemia in Peritoneal Dialysis Patients: No Change in Endothelial Function after Long Term Therapy
Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?
  • K. Kunz, P. Petitjean, +6 authors T. Hannedouche
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 1999
Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease.
Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid.
Treatment with different doses of folic acid in haemodialysis patients: effects on folate distribution and aminothiol concentrations.
  • M. Árnadóttir, V. Gudnason, B. Hultberg
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2000
...
1
2
3
4
...